Green Day bassist Mike Dirnt discusses his new signature model Epiphone Grabber G-3 bass and more topics in an interview with Heavy Consequence.

Math scores in the US have been so bad for so long that teachers could be forgiven for trying anything to improve them. Unfortunately, many of the strategies they’re using could be making things worse ...

Steinberg has launched the next generation of Cubase, bringing a new Expressions Maps system, Melodic Pattern Sequencer and set of six extra Modulators to its well-established flagship DAW, along with ...

Steinberg, the Hamburg-based software manufacturer and developer of music production software such as Cubase, has released two of its most important audio interfaces under freely usable licenses. The ...

New owners Creator Partners and Servco recruit Ben Stahl to lead Reverb's efforts to expand its community of buyers, sellers and creators. By Elizabeth Dilts Marshall Online music instrument and gear ...

Sporting a price north of £1000 at launch, and considering that it only models one amp, the Tone Master Deluxe Reverb is a piece of gear that pushes into the professional category. And it sounds like ...

PLUGIN WEEK 2025: As one of the industry’s most sought-after composers, Jason Graves’ music has won plaudits across the twin worlds of gaming and music production. A quick glance at his impressive ...

PRODUCER WEEK 2025: Reverb is one of the most-used effects in the music producer’s toolkit. Indeed, it’s rare to encounter a song from the last 70 years or so that doesn’t involve reverb in some way.

Etsy acquired the music gear marketplace in 2019 for $275 million. By Elizabeth Dilts Marshall Etsy has agreed to sell Reverb, an online marketplace for musical instruments and equipment, to Creator ...

RockShox’s newest Reverb AXS B1 dropper seatpost is smoother, easier to maintain, costs less and is lighter than before. There’s almost nothing to dislike. But relocating the battery and electronics ...

B.C. biotech startup Reverb Therapeutics has raised $17 million in seed funding to develop a platform that harnesses natural immune system responses to treat diseases. The US$12 million seed funding ...

Reverb looks to treat cancer and autoimmune diseases with its antibody modification platform. Vancouver-based biotech startup Reverb Therapeutics has closed a $12-million USD ($17-million CAD) seed ...